187 related articles for article (PubMed ID: 35241692)
41. Germline PTEN mutations are associated with a skewed peripheral immune repertoire in humans and mice.
Jaini R; Loya MG; King AT; Thacker S; Sarn NB; Yu Q; Stark GR; Eng C
Hum Mol Genet; 2020 Aug; 29(14):2353-2364. PubMed ID: 32588888
[TBL] [Abstract][Full Text] [Related]
42. PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes.
Kurek KC; Howard E; Tennant LB; Upton J; Alomari AI; Burrows PE; Chalache K; Harris DJ; Trenor CC; Eng C; Fishman SJ; Mulliken JB; Perez-Atayde AR; Kozakewich HP
Am J Surg Pathol; 2012 May; 36(5):671-87. PubMed ID: 22446940
[TBL] [Abstract][Full Text] [Related]
43. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
[TBL] [Abstract][Full Text] [Related]
44. Thyroid Follicular Cell-derived Carcinomas in a Background of Multiple Adenomatous Nodules Leading to a Diagnosis of
Liu A; Borges PM; Tay YS; Thompson LDR; Kong MX; Lai J
Anticancer Res; 2022 Mar; 42(3):1481-1485. PubMed ID: 35220242
[TBL] [Abstract][Full Text] [Related]
45. Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly.
McBride KL; Varga EA; Pastore MT; Prior TW; Manickam K; Atkin JF; Herman GE
Autism Res; 2010 Jun; 3(3):137-41. PubMed ID: 20533527
[TBL] [Abstract][Full Text] [Related]
46. A review on age-related cancer risks in PTEN hamartoma tumor syndrome.
Hendricks LAJ; Hoogerbrugge N; Schuurs-Hoeijmakers JHM; Vos JR
Clin Genet; 2021 Feb; 99(2):219-225. PubMed ID: 33140411
[TBL] [Abstract][Full Text] [Related]
47. Cowden syndrome-related mutations in PTEN associate with enhanced proteasome activity.
He X; Arrotta N; Radhakrishnan D; Wang Y; Romigh T; Eng C
Cancer Res; 2013 May; 73(10):3029-40. PubMed ID: 23475934
[TBL] [Abstract][Full Text] [Related]
48. First case report of malignant peritoneal mesothelioma and oral verrucous carcinoma in a patient with a germline PTEN mutation: a combination of extremely rare diseases with probable further implications.
Löffler MW; Steinhilber J; Hilke FJ; Haen SP; Bösmüller H; Montes-Mojarro IA; Bonzheim I; Stäbler A; Faust U; Grasshoff U; Königsrainer I; Rammensee HG; Kanz L; Königsrainer A; Beckert S; Riess O; Schroeder C
BMC Med Genet; 2018 Aug; 19(1):144. PubMed ID: 30111295
[TBL] [Abstract][Full Text] [Related]
49. Thyroid disease in children and adolescents with PTEN hamartoma tumor syndrome (PHTS).
Plamper M; Schreiner F; Gohlke B; Kionke J; Korsch E; Kirkpatrick J; Born M; Aretz S; Woelfle J
Eur J Pediatr; 2018 Mar; 177(3):429-435. PubMed ID: 29273943
[TBL] [Abstract][Full Text] [Related]
50. Cross-level analysis of molecular and neurobehavioral function in a prospective series of patients with germline heterozygous PTEN mutations with and without autism.
Frazier TW; Jaini R; Busch RM; Wolf M; Sadler T; Klaas P; Hardan AY; Martinez-Agosto JA; Sahin M; Eng C;
Mol Autism; 2021 Jan; 12(1):5. PubMed ID: 33509259
[TBL] [Abstract][Full Text] [Related]
51. The gene dosage of class Ia PI3K dictates the development of PTEN hamartoma tumor syndrome.
Wang Q; Weisberg E; Zhao JJ
Cell Cycle; 2013 Dec; 12(23):3589-93. PubMed ID: 24131925
[TBL] [Abstract][Full Text] [Related]
52. Imaging of PTEN-related abnormalities in the central nervous system.
Dhamija R; Hoxworth JM
Clin Imaging; 2020 Apr; 60(2):180-185. PubMed ID: 31927175
[TBL] [Abstract][Full Text] [Related]
53.
Innella G; Bonora E; Neri I; Virdi A; Guglielmo A; Pradella LM; Ceccarelli C; Amato LB; Lanzoni A; Miccoli S; Gasparre G; Zuntini R; Turchetti D
Front Med (Lausanne); 2021; 8():688105. PubMed ID: 34386506
[TBL] [Abstract][Full Text] [Related]
54. Thyroid pathology in PTEN-hamartoma tumor syndrome: characteristic findings of a distinct entity.
Laury AR; Bongiovanni M; Tille JC; Kozakewich H; Nosé V
Thyroid; 2011 Feb; 21(2):135-44. PubMed ID: 21190448
[TBL] [Abstract][Full Text] [Related]
55. Head circumference in the clinical detection of PTEN hamartoma tumor syndrome in a clinic population at high-risk of breast cancer.
Shiovitz S; Everett J; Huang SC; Orloff MS; Eng C; Gruber SB
Breast Cancer Res Treat; 2010 Nov; 124(2):459-65. PubMed ID: 20349131
[TBL] [Abstract][Full Text] [Related]
56. PTEN hamartoma tumor syndromes in childhood: description of two cases and a proposal for follow-up protocol.
Piccione M; Fragapane T; Antona V; Giachino D; Cupido F; Corsello G
Am J Med Genet A; 2013 Nov; 161A(11):2902-8. PubMed ID: 24123798
[TBL] [Abstract][Full Text] [Related]
57. Cerebral MRI and Clinical Findings in Children with
Plamper M; Born M; Gohlke B; Schreiner F; Schulte S; Splittstößer V; Woelfle J
Cells; 2020 Jul; 9(7):. PubMed ID: 32664367
[TBL] [Abstract][Full Text] [Related]
58. Immune dysregulation in patients with PTEN hamartoma tumor syndrome: Analysis of FOXP3 regulatory T cells.
Chen HH; Händel N; Ngeow J; Muller J; Hühn M; Yang HT; Heindl M; Berbers RM; Hegazy AN; Kionke J; Yehia L; Sack U; Bläser F; Rensing-Ehl A; Reifenberger J; Keith J; Travis S; Merkenschlager A; Kiess W; Wittekind C; Walker L; Ehl S; Aretz S; Dustin ML; Eng C; Powrie F; Uhlig HH
J Allergy Clin Immunol; 2017 Feb; 139(2):607-620.e15. PubMed ID: 27477328
[TBL] [Abstract][Full Text] [Related]
59. A pathogenic role for germline PTEN variants which accumulate into the nucleus.
Mingo J; Rodríguez-Escudero I; Luna S; Fernández-Acero T; Amo L; Jonasson AR; Zori RT; López JI; Molina M; Cid VJ; Pulido R
Eur J Hum Genet; 2018 Aug; 26(8):1180-1187. PubMed ID: 29706633
[TBL] [Abstract][Full Text] [Related]
60. Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN.
Busch RM; Srivastava S; Hogue O; Frazier TW; Klaas P; Hardan A; Martinez-Agosto JA; Sahin M; Eng C;
Transl Psychiatry; 2019 Oct; 9(1):253. PubMed ID: 31594918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
